Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation by Sakakura, C et al.
Gastric cancer is the second most common cause of cancer-related
death in the world (Whelan et al, 1993), but the genetic changes
underlying the development and progression of this type of car-
cinoma are poorly understood. We previously analysed chro-
mosomal aberrations in 72 primary gastric cancers by means of
comparative genomic hybridization (CGH) and identified several
high-frequency regions, including 20q with an increased DNA
copy-number whose target genes are as yet unknown (Sakakura 
et al, 1999). Increased DNA copy-number of 20q has also been
observed in bladder, colon and breast cancers, while amplification
on 20q12–13 correlates with the malignant phenotype of breast
cancer (Kallioniemi et al, 1994; Tanner et al, 1995; Vooter et al,
1995; Ried et al, 1996). Recently, several candidate genes for this
amplicon, AIB1, BTAK and Dcr3 have been isolated (Anzick et al,
1997; Sen et al, 1997; Pitti et al, 1998; Zhou et al, 1998). 
BTAK (Breast tumour-amplified kinase, identical to aurora2,
ARK1, AIK, STK15 in alternative names) was cloned from breast
cancers and mapped on 20q13 as a target gene for this amplifica-
tion in human breast cancers and for analysis of its function
(Kimura et al, 1997; Sen et al, 1997; Bischoff et al, 1998; Shindo
et al, 1998; Zhou et al, 1998). The findings of these studies that
BTAK is critical in leading to centrosome amplification, chromo-
some instability, chromosome segregation process and transforma-
tion in mammalian cells. Its role in gastric cancer progression,
however, has not yet been clarified. 
Previous studies have suggested that most cancers with aneu-
ploidy show a more malignant phenotype than those with diploid
(Estiban et al, 1999; Ikeguchi et al, 1999), but the causes of an-
euploidy have not yet been clarified. Identification of mutations in
the mitotic checkpoint gene BUB1 in human cancers was the first
evidence that acquired aneuploidy may be a specific dividing force
in tumour progression, rather than an epiphenomenon of this
disease (Cahill et al, 1998), but its mechanism remains unclear.
Another candidate gene is BTAK. 
To determine the involvement of BTAK in gastric cancer an-
euploidy formation, we analysed the amplification and overexpres-
sion of BTAK and its relation to the DNA ploidy pattern in gastric
cancer. Furthermore, transfection of wild-type BTAK or its dele-
tion mutants was used to analyse the role of BTAK in anuploid
formation in gastric cancer cells. 
MATERIALS AND METHODS 
Tumour samples and cell lines 
All 72 primary gastric cancers were surgically resected specimens.
Their distribution in clinical stage was as follows: stage I, 14 cases;
stage II, 17 cases; stage III, 32 cases; stage IV, 9 cases. High-
molecular-weight DNA was isolated from homogenized tumour
specimens using standard protocols. DNA was isolated from the
peripheral blood of a normal male donor as a reference standard for
CGH. For Southern blot analysis, high-molecular-weight DNA also
was isolated from six gastric cancer cell lines, MKN1, MKN28,
MKN45, MKN74, KATO-III and NUGC-3. The origin, nature and
the number of chromosomes are as follows: MKN1 – metastatic
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lymph node, adenosquamous carcinoma, 39; MKN28 – metastatic
lymph node, moderately differentiated adenocarcinoma, 59–80;
MKN45 – metastatic lymph node, poorly differentiated adenocarci-
noma, 44; MKN74 – metastatic tumour, moderately differentiated
adenocarcinoma, 36; KATO-III – pleural effusion, signet ring cell
carcinoma, 88; and NUGC-3 – metastatic tumour, poorly differen-
tiated adenocarcinoma, 58. These were maintained in RPMI-1640
containing 10% foetal calf serum (FCS). These cell lines were
purchased from Riken cell bank in Japan. 
Southern blot analysis 
Genomic Southern blot was performed as we described previously
(Sakakura et al, 1999). In brief, EcoRI-digested tumour DNA and
human placental DNA (5 mg) were electrophoresed in a 0.8%
agarose gel and transferred to a nylon membrane (Hybond-N,
Amersham Pharmacia Biotech UK Ltd, Buckinghamshire). A 50 ng
aliquot of each probe was labeled with a32P-dCTP using 
random primers, then hybridized to the prehybridized filter. We
analysed signals with a BAS 2000 image analyser (Fuji, Tokyo)
and calculated the degree of amplification. A probe for b-actin was
used to control for loading error. BTAK probe is 248bp cDNA
fragment from nt 1751–nt1998. This cDNA probe was used for
both Southern and Northern blot analysis. 
Northern blot analysis 
Northern blot was performed as we described previously
(Sakakura et al, 1996). In brief, total cellular RNA was prepared
by the guanidine isothiocyanate-phenol-chloroform procedure.
Selection of poly (A)+ RNA was performed by an oligo dT
column, then fractionated on 1% agarose/2.2 M formaldehyde
gels. Probes were labeled with 32P by random priming. Each blot
was hybridized with probes for BTAK and b-actin, as described
previously (Sakakura et al, 1996, 1999, 2000). We analysed
signals with a BAS 2000 image analyser and calculated the degree
of overexpression compared to control. 
Fluorescence in situ hybridization (FISH) 
FISH was carried out as described previously (Ishino et al, 1998).
Interphase nuclei were fixed in methanol and acetic acid (3:1) and
dropped onto microscope slides. 1 ml of Cot-1 was added to 9 ml of
probe hybridization solution. The final mixture was denatured at
75˚C for 10 min, cooled on ice for 5 min, then mixed with an equal
volume of 4 ´ SSC containing 20% dextran sulfate. The hybridiza-
tion mixture was placed on denatured slides, covered with Parafilm,
and incubated in a humidified box for 16 –24 h. After being washed
in 50% formamide/2 ´ SSC, 2 ´ SSC, and 1 ´ SSC. Slides were
counterstained with DAPI (1 mg ml–1) and mounted in an antifade
solution containing p-phenylenediamine (PPD). Fluorescence
images were captured with a Zeiss axiophot microscope equipped
with a charge-coupled device camera. A centromeric probe on chro-
mosome 20, D20Z1 (Oncor, Gaitherburg) was used as an internal
control. The BTAK FISH probe was obtained by screening BAC
clones with a BTAK cDNA probe. 
Semi-quantitative reverse transcriptase-polymerase
chain reaction (RT-PCR) 
Semi-quantitative RT-PCR was performed following the proce-
dure of Nakayama et al (1992). cDNA was produced from total
RNA by using a Superscript preamplification system (BRL,
Bethesda) and following the procedures suggested by the manu-
facturer. RNA was heated to 70˚C for 10 min in 14 ml of
duethylpyrocarbonate-treated water containing 0.5 mg oligo (dT).
Synthesis buffer (10 ´), 2 ml 10 mM dNTP mix, 2 ml 0.1 M DTT,
and reverse transcriptase (Superscript RT, 200 U ml–1) were added
to the sample. The resulting reaction mixture was incubated at
42˚C for 50 min, and reaction was terminated by incubating the
mixture at 90˚C for 5 min. The 100 ml reaction mixture containing
2 ml first-strand cDNA was used for PCR. PCR was performed for
10 –35 cycles in a Perkin-Elmer (Foster City, California) thermal
cycler using a step cycle program at 94˚C for 30 s, 55˚C for 30 s,
and 72˚C for 30 s. After PCR, 10 ml of the reaction mixture was
electrophoresed on a 1.5% agarose gel. The ethidium bromide
fluorescence intensity of the bands was measured with the NIH
image program. A ratio of BTAK overexpression was calculated 
by comparing the signal intensities of b-actin and of BTAK 
in normal mucosa and cancerous tissue. Primer sequences 
used for RT-PCR are as follows: BTAK: forward primer, 
5¢-TAGGCATGGTGTCTTCAC-3¢, reverse primer, 5¢ -
CATTCCTAAAGGAATGCC-3¢;  b-actin: forward primer, 5¢-
GAGCTGCGTGTGGCTCCCGAGG-3¢, reverse primer,
5¢-CGCAGGATGGCATGGGGGAGGGCATACCCC-3¢. 
Western blot analysis 
Western blot analysis was performed as described previously
(Sakakura et al, 1996). Cells were washed twice with PBS and
lysed in 1% Triton X-100, 0.15M NaCl and 10 mM Tris HCl, pH
7.4, with 50 mgm l –1 PMSF at 4˚C for 60 min. Lysates were
centrifuged at 10 000 rpm for 10 min. Samples were boiled in SDS
sample buffer for 5 min before running on a 10–20% SDS-
polyacrylamide gel after overnight transfer of SDS-polyacrylamide
gel to nitrocellulose membrane. After blocking the blot in 3% BAS
for 2 h at room temperature, immunodetection of BTAK was
performed with monoclonal antibody IAK1 (mouse monoclonal
antibody, Transduction Laboratories, Lexington) at 1:250 dilution
for 24 h at room temperature. Horseradish peroxidase-conjugated
anti-mouse IgG antibody was incubated with the blot at 1:1000
dilution in PBS with 1% non-fat dry milk. The blot was visualized
with ECL kit (Amersham). 
Vector constructs 
The expression vector pCX2neo BTAK was used for all experi-
ments. This vector places the human BTAK under the transcrip-
tional control of b-actin promoter and CMV enhancer as described
previously (Niwa et al, 1991; Sakakura et al, 1994). Several dele-
tion mutants were prepared as shown in Figure 5A. 
Transfection 
Gastric cancer cell line MKN1, MKN45 and MKN74 cells were
stably transfected with pCX2neoBTAK or native pCX2neo vector
using Lipofectin (GIBCO, Grand Island) as described previously
(Sakakura et al, 1994, 1996). These gastric cancer cell lines
MKN1, MKN45 and MKN74 are near-diploid, and we have
selected the near-diploid cells for the experiments of BTAK trans-
fection. Cells (2 ´ 104) were plated on 35-mm dishes in serum-free
media and transfected with 2 mg of pCX2neoBTAK or pCX2neo826 C Sakakura et al 
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DNA. Each transfection was performed two separate times to
ensure the generation of unique clones. At 24 h following transfec-
tion, RPMI with 20% FCS was added to the plates. After 48 h, the
cells were trypsinized and transferred to 100-mm dishes, and the
following day media was supplemented with 1 mg ml–1 G418
(GIBCO) and cultured for 4 weeks. Individual G418-resistant
clones were generated by limited dilution. 
BTAK expression was determined by RT-PCR. For RT-PCR,
primer sequence sense primer 5¢-GCAACGTGCTGGTTGTTG-3¢
corresponds to the sequence in the globin gene in pCX2neo vector.
Antisense primer site is as shown in Figure 5A. 
Measurement of DNA ploidy pattern by flow cytometry 
Preparation of the cell suspensions and measurement of nuclear
fluorescence were performed according to the method described
previously (Ohta et al, 1995). Briefly, the tumour material was
mechanically minced with scissors and the tissue pieces were
suspended in Hank’s balanced solution, passed 10–20 times
through a sharp-edged glass pipette, and the resultant cell suspen-
sion filtered through gauze. The cell pellet (1 ´ 106 cells), obtained
by 200 g centrifugation, was suspended in 1 ml of fluorochrome
solution (50 mg ml–1 propidium iodine, 0.1% sodium citrate, 0.1%
Triton X-100). Samples were plated overnight in the dark at 4˚C,
and fluorescence of individual nuclei was measured using an
FACS flow cytometer (FACS Vantage™, Becton-Dikinson)
equipped with an argon ion laser, with a propidium iodide extrac-
tion of 488 nm and fluorescence emission of 590 nm. 
Statistical methods for analysis 
Statistical analysis was performed using version 4.0 of the NAP
system programmed by Aoki (1989). The first objective of the
statistical analysis was to examine the influence of BTAK ampli-
fication on DNA ploidy pattern with unpaired t-test. The various
groups of patients were compared by means of either c2 test or
Mann-Whitney U test. Results with P values of less than 0.05 were
considered statistically significant. 
RESULTS 
Southern blot analysis 
Southern blot analysis demonstrated amplification in four cases
(5%). Typical data are shown in Figure 1A. Intense bands were
observed in lanes 3, 4, 5 and 6 (3.5-fold, 5.1-fold, 5.8-fold and 6.3-
fold, respectively compared to control lane 1). A b-actin probe was
used as a control for loading errors in the lanes. 
Fluorescence in situ hybridization 
Tumours were categorized into three groups according to BTAK
copy-number, using the classification of Meltzer et al low – fewer
than four copies or no increase in number; moderate – 4 – 6 copies
per cell or a 1.5–3.0-fold increased relative copy-number; high –
more than six copies per cell or > 3-fold relative copy-number
increase. Thirty-four of 72 gastric cancers showed an increase in
the number of copies. Typical data is shown in Figure 1B.
Numerous copies of BTAK (red signals) were resolved in large
interphase nuclei (a = control, normal pattern of peripheral
lymphocyte; b, c and d = high-level amplification). Green signal
indicates internal control of chromosome 20. FISH analysis
revealed high-level amplification in four cases (5%), moderate-
level amplification in 11 cases (15%), and low-level amplification
in 19 cases (28%). 
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Figure 1 (A) Southern blot analysis demonstrates amplification of BTAK in
primary gastric cancers. 5 mg of Eco R-I-digested DNA was loaded per lane.
The degree of amplification was calculated with a BAS4000 image analyser.
Rehybridization was performed on the same membrane with b-actin (ACTB)
as a control for DNA loading error. (B) Bicolour FISH analysis demonstrates
BTAK amplification (red signals) in gastric cancer cells. Numerous copies of
BTAK were resolved in interphase nuclei. The digoxigenin-labelled BTAK P1
probe was hybridized with a biotinylated reference centromeric probe on
chromosome 20 which appears green. Representative nuclei of gastric
cancers show various patterns of signal exhibiting: (a) disomy; (b, c and d)
high-level amplification. 
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Figure 2 Northern blot analysis of BTAK demonstrates increased
expression relative to normal gastric mucosa (control) in the gastric cancer
cell lincs MKN1, MKN 28, MKN 45, MKN 74, KATO-III and NUGC-3. The blot
was hybridized sequentially with the indicated probes to compare BTAK
expression with that of b-actin. BTAK amplification and overexpression in gastric cancers 827
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Northern blot analysis 
BTAK expression was examined in six gastric cancers and
compared with b-actin expression by Northern blotting. These
cells did not show high-level amplification (data not shown), but
indirectly proportional to amplification, BTAK was highly overex-
pressed in all lines except MKN1 Figure 2. 
Semi-quantitative RT-PCR 
Informative results were obtained in 35 of 72 cases. Representative
cases of BTAK/b-actin expression are shown in Figure 3A. Signals
observed in cancerous tissues were intensive in comparison with
the signals of normal gastric mucosa in cases 3, 9, 17 and 29.
BTAK/b-actin ratios are plotted in Figure 3B. BTAK expression in
primary gastric cancers increased relative to that in normal gastric
mucosa in 18 of 35 cases (51%, P < 0.05, two tailed t-test). 
Relationship between DNA ploidy pattern and BTAK
amplification or its overexpression 
All four cases with BTAK amplification showed aneuploidy forma-
tion. The incidence of cases of aneuploidy with BTAK ampli-
fication was significantly higher than that of cases without
amplification (P < 0.05). The incidence of cases of aneuploidy
with BTAK overexpression was somewhat higher than that of cases
without BTAK overexpression, but not significantly (Figure 4). 
Schematic representation of BTAK-deletion mutants
and expression of the transfected genes in stable
transfect 
Schematic representation of BTAK and its deletion mutants are
shown in Figure 5A. Expression of the transfected genes in the
cells was confirmed by RT-PCR analysis. The locations of the
antisense primers used for the analysis are indicated in Figure 5A.
Fragments of the expected size were amplified in all cases in each
cell line: 1201 bp for wild-type BTAK, 913 for delBTAK1
(BTAKD 354 – 403), and 672 bp for delBTAK2 (BTAKD55–134)
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Figure 3 (A) RT-PCR analysis of BTAK/b-actin mRNA expression in normal gastric mucosa and cancerous tissue. Four representative cases of BTAK/b-actin
expression are shown. A (T = tumour; N = paired non-cancerous tissue). (B) BTAK/b-actin ratios in normal gastric mucosa and cancerous tissue. Figures
represent the mean ± standard deviation* P < 0.05, two tailed t-test 
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Figure 4 (A) Relationship between DNA ploidy and BTAK amplification, *P
< 0.05, two tailed t-test. (B) Relationship between DNA ploidy and BTAK
overexpression, *P < 0.07, not significant 
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(Figure 5B). Two independent clones of each stable transfectant
were selected and their expression examined. None of the PCR-
product was detected in cells transfected with the plasmid
harbouring only the neomycin-resistant gene. 
Morphological changes in stable transfectant 
Three independent experiments with cells stably transfected with
wild-type BTAK showed that these cells have a large body, with a
multiple nucleus in MKN1 cells (Figure 6A, 6B and 6C).
Transfection and overexpression of BTAK were detected in stable
transfectants of gastric cancer cell lines as shown in Figure 5.
Figure 6D shows the cells transfected with the plasmid harbouring
only the neomycin-resistant gene. 
Changes of cell proliferation in stable transfectants 
As shown in Figure 7A, MKN1 cells with delBTAK2
(BTAKD55–134) did not show any appreciable change in their
growth rates, while MKN1 cells with BTAK showed a slight
increase in their growth rates. In contrast, expression of delBTAK1
(BTAKD354 – 403) significantly prolonged the doubling time
from 35–100 h. In the another cell line, MKN74, the same
tendency was observed in each stable transfectant, but not in
MKN45 and NUGC3. 
Measurement of DNA ploidy pattern by flow cytometry 
The DNA content of aneuploid cells resulted in an unequivocal
hyperdiploid DNA peak which was distinguishable from the diploid
DNA peak in MKN1/BTAK cells, as shown in Figure 7B. As shown
in Figure 7B, aneuploid cells were observed in only 5 –10% of
parental MKN1 and MKN1/CX cells (control), but in 30 – 40% of
MKN1/BTAK. The percentage of aneuploid cells in MKN1/BTAK
cells was significantly higher than that in the parent MKN1 cells and
MKN1/CX cells (control). In the another cell line, MKN74, the
same tendency was observed in each stable transfectant. 
Western blot analysis 
We examined expression of BTAK protein in three independent
clones of MKN1 cells stably transfected with wild-type BTAK
(clone 1, clone 2 and clone 3) by Western blot analysis. As shown
in Figure 8, stable transfectants of BTAK showed strong expres-
sion of BTAK protein at molecular size of 46 kD compared to
control cells, to which only neomycin-resistant genes were intro-
duced. Anti-b-actin antibody was used to exclude loading error. 
DISCUSSION 
Gene amplification of MET, MYC, HST1/INT2, ERBB2 and other
genes has been reported in gastric cancer as a marker of poor
prognosis (Ranzani et al, 1990; Tahara, 1995). Our recent analysis
using comparative genomic hybridization of chromosomal aberra-
tions in gastric cancers has revealed an unusual frequency of
increases in the number of copies in the long arm of chromosome
20, indicating that this region contains a novel amplified gene
involved in gastric cancer progression. BTAK (identical to aurora2,
ARK1, AIK, STK15 in alternative names) has been cloned on
20q13 as a candidate target gene for this amplification in human
breast cancers (Kimura et al, 1997; Sen et al, 1997; Bischoff et al,
1998; Shindo et al, 1998; Zhou et al, 1998). 
This gene is a cell-cycle regulated serine-threonine kinase and is
the first example to suggest a link between centrosome integrity
and cellular transformation (Bischoff et al, 1998; Bischoff and
Dlowman, 1999). Until recently, no compelling connection could
be established between the proteins involved in this process of
chromosome seggregation and cancer. However, amplification and
overexpression of BTAK cause centrosome amplification, deregu-
lated duplication, and aneuploid formation, thus suggesting that it
is implicated in the centrosome segregation abnormalities and
aneuploidy seen in many cancer cell types (Zhou et al, 1998). 
We examined the number of BTAK copies, their expression 
and their relation to DNA ploidy patterns in 72 primary gastric
cancers. In all cases a gain on chromosome 20q detected by CGH
could be confirmed by FISH, but the number of BTAK copies
increased more than expected after CGH and high-level amplifica-
tion of BTAK was identified in four cases (5%), and overexpres-
sion in more than 50% of the primary gastric cancers tested. BTAK
amplification coincided with this overexpression, but many cases
showed BTAK overexpression without amplification, suggesting
that the expression of BTAK is likely to be regulated not only by
gene amplification but also by other mechanisms such as transcrip-
tional activation in human gastric cancers. These findings suggest
that BTAK is one of the putative target genes in this region of
frequent increases in the number of copies in primary gastric
cancers. All cases with BTAK amplification showed aneuploidy.
Cases with BTAK-overexpression showed the same tendency but
not significantly. These results indicate that BTAK may be at least
partly involved in gastric cancer aneuploidy. 
Figure 5 (A) Schematic representation of BTAK and its deletion mutants.
Wild-type BTAK, delBTAK1 (BTAKD354 – 403), and delBTAK2
(BTAKD55–134) are represented by solid bars. The figures indicate the
number of amino acids in the polypeptides. The antisense primers used for
RT-PCR analysis are indicated by bars. (B) RT-PCR analysis of transfected
genes in each stable transfectant 
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Next, we analysed the roles of BTAK using transfection of
several kinds of deletion mutants in gastric cancer cell lines. 
After transfection was established, we compared morphological
changes, DNA ploidy pattern and proliferation rate. Stable trans-
fectants of wild-type BTAK showed large cells with large multiple
nuclei, and overexpression of BTAK enhanced cell proliferation to
some extent. In contrast, c-terminal deletion mutants inhibited cell
proliferation, probably due to dominant negative effect. FACS
analysis revealed the existence of another cell population, indi-
cating that the ancuploid cell population appeared in a stable trans-
fectant. 
These findings as well as the observation of growth inhibition
by deletion mutants and morphological changes in wild-type
BTAK-stable transfectants, suggest that BTAK is, at least in part,
involved in gastric cancer cell proliferation through chromosome
segregation and aneuploidy formation. BTAK amplification and
overexpression was frequently observed in aneuploid gastric
cancer cells, but we hypothesize that BTAK is not the only cause of
aneuploidy, since many genes could be involved in gastric cancer
aneuploidy formation. For example, mutations found in the mitotic
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Figure 7 Cell proliferation and DNA ploidy pattern of BTAK-transfected cell.
(A) Growth curve of gastric cancers MKN1. Cells were seeded in growth
medium on day 0 and incubated for 72 h. Each stable transfectant of wild-
type BTAK (l), del BTAK1 (s), del BTAK2 (u) and control (l l) in fresh
medium. The results represent the mean ± standard deviation from triplicate
cultures. Student’s t-test shows that difference between the stable
transfectant of wild-type BTAK and that of del BTAK 2 to be statistically
significant (P < 0.05). (B) FACS analysis. The DNA content of aneuploid cells
resulted in an unequivocal hyperdiploid DNA peak which was distinguishable
from the diploid DNA peak in MKN1/BTAK cells 
Figure 6 Morphological changes in wild-type BTAK-transfected cells. (A, B and C) Stable transfectants of BTAK, (D) control 
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checkpoint gene BUB1 in human cancers indicate that acquired
aneuploidy may be a specific phenomenon in tumour progression,
rather than an epiphenomenon of this disease (Cahill et al, 1998).
MET is also known to mediate non-random chromosome duplica-
tion (Zhuang et al, 1998). These cancers have chromosome instab-
ility and in case of additional genetic changes easily become
aneuploid even if the cancer cells are still diploid. This could in
turn contribute to the rapid growth kinetics in the subset of gastric
cancers. 
Previous studies indicate that overexpression of BTAK is trans-
forming only in the presence of co-amplification or mutation of
additional genes (Zhou et al, 1998). Likewise in our study, BTAK-
transfection induced aneuploid cells in MKN1 and MKN74, but
not in MKN28 or NUGC3 cells. The morphologically changed
cells would need to maintain an appropriate BTAK expression
level or additional changes of other genes. Further studies will be
needed to clarify the mechanisms of aneuploid formation. 
A previous interphase FISH study demonstrated that amplifica-
tion of chromosome 20q in breast cancer was complex and
involved several distinct variably co-amplified segments derived
from 20q11, 20q12, and 20q13 (Tirkkonen et al, 1998). In breast
cancer, most instances of BTAK amplification were observed in
conjunction with an increase in the number of 20q12 copies.
Similarly, a complex amplification on 20q may occur in gastric
cancers. Recently, the AIB1 gene was localized on 20q12 as a putat-
ive target gene (Anzick et al, 1997; Sakakura et al., 2000), which
may be involved in gastric cancer progression. 
Recently we analysed amplification of putative target genes 
on 20q12–13 including BTAK (20q13) and AIB1 (20q12).
Coamplification of BTAK and AIB1 was observed in four cases of
Table 1 (data not shown), and these cases had poor prognosis than
cases without BTAK amplification. We have not yet been able to
clarify which gene is important in this region, but it appears that
multiple genes on this locus are involved in the progression of
gastric cancers. Further studies are now underway to clarify their
respective roles. 
In conclusion, dysregulation through BTAK gene amplification
and overexpression provides a selective advantage for tumour
growth and aneuploid formation in gastric cancers. A previous
study indicated that most cancers with aneuploidy show a more
malignant phenotype than diploid cancers (Estiban et al., 1999;
Ikeguchi et al, 1999). As the incidence of BTAK amplification and
overexpression in gastric cancers was found to be as high as in
breast cancers and colon cancers, the frequent amplification and
overexpression of BTAK may indicate that aneuploid formation
confers a growth advantage even on gastric cancer cells. These
observations suggest that the altered expression of BTAK may
contribute to a more malignant phenotype of gastric cancer.
Amplification and overexpression of BTAK appears to be important
in chromosomal segregation and aneuploid formation, and may be
involved in the development of a clinically aggressive subset of
gastric cancer. In other words, BTAK may be a marker of poor
prognosis. 
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